The Democratic Republic of Congo is facing its deadliest Ebola outbreak, with over 2,300 deaths and 4,945 cases as of August 2026. Caused by the rare Bundibugyo virus with no approved vaccines, the outbreak is killing one person every 30 minutes and spreading across six provinces. Exhausted health workers struggle with contact tracing amid unpaid strikes, rebel threats, community mistrust, and misinformation. The WHO warns it could become the worst in history, while the UN has allocated $30.5 million and deployed additional staff to contain the crisis.
The Democratic Republic of Congo is battling its fastest-growing and second-deadliest Ebola outbreak, caused by the Bundibugyo virus with no approved vaccines. Over 1,700 deaths and 3,900 cases have been recorded, concentrated in Ituri province. The response is crippled by community mistrust, armed conflict, attacks on health centers, and a strike by unpaid health workers. The WHO and Africa CDC are investigating a possible virus mutation as the outbreak threatens regional stability.
On August 10-11, 2026, U.S. President Donald Trump signed an executive order reducing recommended childhood vaccines from 17 to 11 diseases, removing universal recommendations for hepatitis B, COVID-19, and flu. The order also calls for splitting the combined MMR vaccine into three separate shots, based on debunked claims linking vaccines to autism. Health experts and lawmakers strongly oppose the move, warning it increases infection risks amid a major measles outbreak. The order’s impact is limited as states control vaccine mandates.
Uganda's health authorities declared the country Ebola-free on July 28, 2026, after its last patient completed a 42-day monitoring period without new infections. The outbreak in Uganda resulted in 20 confirmed cases and two deaths. However, the situation remains dire in neighboring Democratic Republic of Congo, where cases have reached 3,262 with 1,437 deaths, nearing the record of the 2018-2020 outbreak. The Africa CDC warned that funding needs have tripled to $1.4 billion, and the WHO reported that cases are still spreading undetected. The U.S. submitted a $1.4 billion supplemental funding request to Congress, while protests in Kenya over a planned U.S.-backed quarantine facility led to two deaths. The WHO also noted that the outbreak could become the worst on record if not contained soon.
Devastating wildfires are sweeping across Southern and Western Europe, driven by extreme heat and dry conditions. In southwestern France, over 63,000 people have been evacuated near Bordeaux and the Arcachon Basin, with fires spreading to 10,000 hectares. Spain declared a state of emergency for Madrid and Ávila, evacuating 10,000 people. France activated EU civil protection, requesting aircraft from Croatia, Portugal, Czech Republic, and Slovakia, and is converting an A400M military plane for firefighting. Fires also hit Sicily, where a firefighter died, and Germany’s Saarland region.
The Ebola outbreak in the Democratic Republic of Congo has surpassed 1,000 deaths, with 2,536 cases reported since May 15, making it the fastest-growing outbreak on record, according to African health officials. The Bundibugyo virus strain responsible has no approved vaccines or treatments. Dr. Jean Kaseya, head of the Africa CDC, stated at a health summit in Ghana that people are dying due to lack of vaccines, medicine, and funding. The current outbreak is spreading faster than health officials can track, compared to the 2013-2016 outbreak which took eight months to reach 1,000 deaths. A Merck Ebola vaccine licensed for the Zaire virus may offer some cross-protection against Bundibugyo, according to a New England Journal of Medicine study, but the WHO has expressed lukewarm support for testing it in Congo. Bundibugyo-specific vaccines remain months away from clinical trials.
The Ebola outbreak in the Democratic Republic of Congo has surpassed 1,000 deaths, with 2,536 cases reported since May 15, making it the fastest-growing outbreak on record. The Bundibugyo virus strain responsible has no approved vaccines or treatments. Dr. Jean Kaseya of the Africa CDC highlighted the lack of vaccines, medicine, and funding as contributing to deaths. The current outbreak is spreading faster than health officials can track, compared to the 2013-2016 outbreak which took eight months to reach 1,000 deaths. A Merck Ebola vaccine licensed for the Zaire virus may offer some cross-protection against Bundibugyo, according to a New England Journal of Medicine study, but the WHO has shown lukewarm support for testing it in Congo. Bundibugyo-specific vaccines remain months away from clinical trials.
The Ebola outbreak in the Democratic Republic of Congo has surpassed 1,000 deaths, with 2,536 cases reported since May 15, making it the fastest-growing outbreak on record. The Bundibugyo virus strain responsible has no approved vaccines or treatments. Dr. Jean Kaseya, head of the Africa CDC, highlighted the lack of vaccines, medicine, and funding as contributing to fatalities. The current outbreak is spreading faster than health officials can track, compared to the 2013-2016 outbreak which took eight months to reach 1,000 deaths. A Merck Ebola vaccine licensed for the Zaire virus may offer some cross-protection against Bundibugyo, according to a New England Journal of Medicine study, but the WHO has shown lukewarm support for testing it in Congo. Bundibugyo-specific vaccines remain months away from clinical trials.
The 'Let's Fix Our Food' (LFOF) Consortium, led by the ICMR-National Institute of Nutrition (NIN), has released a policy document recommending healthier school food environments, stricter regulation of unhealthy food marketing to children, front-of-pack nutrition labelling, and taxation of high-fat, sugar and salt (HFSS) foods. The recommendations aim to combat rising obesity and diet-related non-communicable diseases (NCDs) among children and adolescents in India. The document, titled 'Priority Policy Actions to Promote Healthier Diets and Food Environments for Children and Adolescents in India,' was launched by NITI Aayog Member (Health) M Srinivas during a workshop. The consortium includes partners such as UNICEF India, the World Health Organization, the Public Health Foundation of India, and the Food Safety and Standards Authority of India (FSSAI). The workshop also launched several knowledge products, including the Nutrition Environment Assessment Toolkit for Schools (NEAT-S) and an e-learning module on food labels.
This article from The Hindu examines why Attention-deficit/hyperactivity disorder (ADHD) is frequently undiagnosed in adults, particularly older adults. Despite being a neurodevelopmental disorder that begins in childhood, ADHD often persists into adulthood but is widely misperceived as a childhood condition. Experts explain that inattentive symptoms, effective coping strategies, and family support can mask the disorder for decades. Symptoms like disorganization and forgetfulness are often mistaken for normal aging, depression, or dementia. Life changes such as retirement or loss of a spouse can remove external structures, revealing long-hidden challenges. The article highlights that diagnosis is complicated by symptom overlap with other conditions and that awareness is crucial for identifying undiagnosed individuals.
A study published in Lancet Public Health reveals that global road injury and death rates have fallen more than 30% between 1990 and 2023, but progress is uneven. While high-income countries like the U.S. have seen recent declines—U.S. road deaths fell to about 36,600 in 2025 after peaking at 43,000 in 2021—low-income countries still account for 90% of road fatalities. The World Health Organization reported that traffic crashes killed over 1.1 million people in 2025 and remain the leading cause of death for those aged 5-29. Factors include lack of safety measures in poorer nations, larger vehicles in the U.S., and distracted driving. The findings coincide with a UN high-level meeting on global road safety in New York City.
The Financial Times reports on the surging use of tanning beds despite strong expert warnings. The World Health Organization classifies sunbeds as a Group 1 carcinogen, on par with cigarettes and plutonium. A 2021 analysis of 14,000 melanoma patients showed increased risk from sunbed use, and UK government advisors found that using sunbeds before age 35 raises melanoma risk by 75%. The British Association of Dermatologists supports a complete ban on commercial sunbeds in the UK, citing links to skin cancer and poor enforcement of regulations. Brazil, Iran, and Australia have already banned sunbeds. While some users claim benefits like improved mood, treatment of skin conditions, and vitamin D production, dermatologists emphasize that commercial sunbeds deliver predominantly UVA light in uncontrolled doses, unlike safe clinical light treatments. Experts recommend vitamin D supplements as a safer alternative and note that sunbeds accelerate skin aging by damaging DNA and collagen.
The Financial Times reports a rise in legal disputes over wills, driven by an aging global population, increasing dementia cases, and the 'great wealth transfer' of $18tn from baby boomers. Lawyers and advisers note that challenges often hinge on proving the testator lacked mental capacity at the time of making the will. Capacity is complex and can fluctuate, making litigation difficult. Blended families and UK tax changes further fuel conflicts. The article includes a case study where a power of attorney prevented a sibling from misusing funds, and expert commentary on the legal and psychiatric dimensions of capacity assessments.
The article examines the contradiction between the Trump Administration's 'Make America Healthy Again' (MAHA) initiatives and its policies on glyphosate. On June 25, 2026, the Supreme Court ruled 7-2 that Bayer/Monsanto is shielded from state-level lawsuits over Roundup's alleged cancer risks. Hours later, President Trump signed an Executive Order promoting regenerative agriculture, which activists say is undermined by continued glyphosate use. The EPA subsequently approved new uses of 'forever chemicals' as pesticides. MAHA leader HHS Secretary RFK Jr. has championed beneficial health measures like banning artificial dyes, but critics argue the administration simultaneously grants legal immunity to pesticide companies. Glyphosate is sprayed on 300 million acres of US farmland annually and is classified as a probable carcinogen by the WHO. Activists express disappointment that the administration's actions favor industry over public health.
Aurobindo Pharma's subsidiary CuraTeQ Biologics has received approval from Brazil's health regulator Anvisa for its biosimilars manufacturing facility in Hyderabad, India. The facility underwent a Good Manufacturing Practice (GMP) inspection by Anvisa from May 11-15, 2026, covering four biosimilar products, mammalian and microbial drug substance manufacturing, prefillable syringe and vial filling, packaging, labeling, and QC testing. The approval enables CuraTeQ to enter the broader Latin American market. The facility is already certified by the European Medicines Agency (EMA) and the World Health Organization (WHO), underscoring its global compliance standards.
The 42nd episode of The Hindu's Health Wrap, hosted by Health Editor Ramya Kannan and Senior Assistant Editor Zubeda Hamid, provides a concise roundup of the week's major health stories. Key topics include the WHO's latest report highlighting global cancer inequalities and advances in cancer detection and treatment, the health impacts of extreme heat, updates on infectious disease outbreaks, innovations in diabetes care, and important public health explainers. The episode offers a comprehensive overview of pressing health issues from a global and Indian perspective.
India has approved QDENGA, its first dengue vaccine, manufactured by Takeda Biopharmaceuticals. The Drug Controller General of India (DCGI) granted market authorization for use in individuals aged 4 to 60, administered in two doses three months apart. The vaccine protects against all four dengue serotypes. Clinical trials involving over 28,000 participants showed 80.2% efficacy against virologically confirmed dengue 12 months after the second dose and 90.4% efficacy against dengue-related hospitalization at 18 months. India accounts for about one-third of the global dengue burden, with over 121,000 cases reported last year. The vaccine represents a significant shift from relying solely on vector-control measures, though experts note varying effectiveness across serotypes.
This analysis examines the significance of the Supreme Court of India's June 2026 ruling in Maniyar Iliyaz vs P. Ayyappan, which declared walking on demarcated footpaths a fundamental constitutional right under Articles 19(1)(d) and 21. The article argues that safe, accessible footpaths are a test of governance and a critical public health intervention. It cites WHO data showing 49.4% of Indian adults and 74% of adolescents do not meet recommended physical activity levels, contributing to rising metabolic diseases. Additionally, road safety data from 2024 reveals pedestrians and two-wheeler riders account for nearly 67% of road fatalities. The piece critiques episodic anti-encroachment drives and calls for systematic urban planning that prioritizes pedestrians over vehicles, framing walkability as preventive medicine and a democratic imperative.
Kerala has launched a State Action Plan for Prevention and Control of Snakebite Envenoming (SAPSE) aiming for zero snakebite deaths and disabilities by 2030, aligning with WHO and national targets. The plan, built on the 'One Health' platform, focuses on strengthened primary care, improved emergency facilities, enhanced surveillance, community awareness, and intersectoral coordination. Key measures include declaring snakebite a notifiable disease, establishing a tiered referral system (L1 basic stabilization within 30 minutes, L2 with ICU, L3 tertiary care), setting up a 24-hour helpline, expanding ambulance coverage, improving anti-snake venom supply chains, and training healthcare personnel. Data-driven surveillance will integrate health and forest department data to generate risk maps. A separate Tribal Sub-Action Plan addresses vulnerable forest-fringe communities. The plan involves multiple departments including Health, Forest, Agriculture, and Education.
The Drug Controller General of India (DCGI) has granted market authorisation to Takeda Biopharmaceuticals India's QDENGA (TAK-003), making it the first dengue vaccine approved in the country. The live-attenuated tetravalent vaccine is approved for individuals aged 4 to 60 years and is administered as a two-dose regimen three months apart. It can be given without prior dengue screening and protects against all four dengue virus serotypes. Approval is based on Takeda's global clinical programme including the Phase III TIDES trial, which showed 80.2% efficacy against virologically confirmed dengue 12 months after the second dose and 90.4% efficacy against dengue-related hospitalisation at 18 months. Follow-up data at 4.5 years showed 84.1% efficacy against hospitalisation. QDENGA has been approved in 43 countries, is WHO-recommended and prequalified, and is included in Brazil's National Immunization Program. India accounts for nearly one-third of the global dengue burden.
This article from The Hindu explores how leprosy, a disease historically associated with severe stigma, ostracization, and loss of dignity, has been a potent subject in Tamil literature. It focuses on two novels: Sahitya Akademi Award-winning author Imayam's 'Noiputtru', set in the 1960s, which chronicles the disease's progression and the grim resignation of patients confined to leprosy homes; and Karichan Kunju's 'Pasitha Manidam', set earlier, which follows a wealthy Brahmin, Ganesan, who suffers a merciless social descent due to the disease. The article contrasts the experiences of the protagonists, highlighting that leprosy respects no social status. It notes that before the WHO's Multi-Drug Therapy (MDT) breakthrough in the 1980s, treatment could only slow the disease, not cure it, leaving patients to face disfigurement, isolation, and a slow erosion of human dignity.
The article chronicles the 60+ year history of the Blue Cross of India (BCI), founded in 1964 by Captain V. Sundaram, a pioneering commercial pilot, and his family in Chennai. Starting with rescuing two stranded puppies in 1959, the organization grew from an informal Animal Aid Association into India's most influential animal welfare body. Key contributions include developing the Animal Birth Control (ABC) program—a 'catch, sterilize, and return' method—as an alternative to the failed municipal dog culling policy that dated back to 1860. The BCI transitioned from volunteer-run operations to a professionally managed organization with international support by the late 1980s. The World Health Organization endorsed the ABC-AR approach in 1990, and Chennai's municipal corporation stopped culling dogs in 1996. The article highlights the organization's role in filling gaps in civic systems and setting standards for animal welfare in India.
The Saint Michael Center for Spiritual Liberation and Exorcism in Metro Manila, Philippines, is Asia's only dedicated exorcism training facility. Opened five months ago, it trains priests from across the region, including Singapore, Malaysia, Cambodia, and India. Founder Father Jose Francisco Syquia says trauma from bullying, sexual abuse, and family separation has increased cases of perceived spiritual attacks. The center follows Church rules requiring mental health vetting, with psychologists and psychiatrists on staff. However, mental health experts warn that attributing conditions to demonic possession can delay proper medical treatment. In the Philippines, where there is only one psychiatrist per 200,000 people, many prefer exorcism over psychiatric care due to stigma.
A series of news reports indicate that the Ebola outbreak in the Democratic Republic of the Congo is escalating, with safety concerns severely limiting the response. Over 12 attacks on healthcare workers and facilities have been recorded, hindering containment efforts. The World Health Organization (WHO) warns that the outbreak is outpacing the response, while neighboring Uganda has reached a milestone in its own preparedness. The situation is described as getting out of control, with the phenomenon of 'walking Ebola'—where infected individuals travel while symptomatic—complicating containment. The outbreak involves the Bundibugyo virus strain, adding to the challenges faced by health authorities.
Uganda discharged its last Ebola patient on July 16, 2026, starting a 42-day countdown to be declared Ebola-free by the WHO. Health Minister Chris Baryomunsi confirmed that all 20 cases in Uganda were imported from neighboring Democratic Republic of Congo, with only two deaths. In contrast, the DR Congo outbreak is worsening, with over 2,000 confirmed cases and more than 700 deaths. The virus, a rare Bundibugyo strain, has spread to multiple provinces, including Haut-Uélé and Tshopo, near borders with South Sudan and the Central African Republic. The WHO classified the outbreak as an international health emergency in May. Dilapidated healthcare systems and ongoing armed conflicts in the region complicate containment efforts. Genetic analysis shows that vaccines and treatments for this strain are still under development.
EU officials held a day of remembrance for victims of last month's record-breaking heatwave, which caused around 10,000 excess deaths across Western Europe, including 5,000 in Germany alone. EU climate chief Teresa Ribera stated that climate change is a killer and that Europe is not prepared for its risks. The European Commission will table a concrete proposal for a new climate adaptation plan by year's end, prioritizing emissions cuts and building resilience to extreme weather. A WHO official suggested that declaring the climate crisis a global public health emergency could trigger more urgent action. The European Environment Agency noted that citizens and businesses face around €50 billion in annual climate damages, roughly equal to the EU's agricultural budget. Political divisions persist over whether the EU should focus on mitigation or adaptation, such as the uptake of air conditioning.
A U.S. citizen working for a humanitarian organization in the Democratic Republic of Congo tested positive for Ebola amid a record outbreak. This is the second American infected in the region. The patient was transferred to Frankfurt University Hospital in Germany for treatment and is in stable condition. The CDC and WHO are coordinating contact tracing and containment efforts. The U.S. also announced restrictions on citizens in DRC traveling home due to the outbreak.
The World Health Organization (WHO) has officially updated the number of confirmed hantavirus infections linked to a suspected outbreak on a cruise ship. The total count has been revised downward from nine to eight individuals. In its latest assessment, the WHO stated that there have been no reports of genetic mutations in the virus that would increase its infectivity or transmissibility. Consequently, the health agency maintains that the risk of the infection spreading to the general public remains low. This update follows previous recommendations by the WHO, which had advised a 42-day quarantine period for all crew members and passengers aboard the affected vessel. The revision in case numbers suggests a refinement in diagnostic confirmation or data verification processes. The absence of concerning mutations is a critical factor in determining the potential scale of the outbreak, indicating that the virus behaves according to known patterns without enhanced contagiousness. Authorities continue to monitor the situation closely to ensure containment within the isolated environment of the cruise ship, aiming to prevent any broader community transmission.
Dr. Brian Christine, a urologist specializing in penile implants with a history of promoting conspiracy theories, has been appointed to lead the U.S. federal response to a hantavirus outbreak. The appointment has drawn significant criticism due to his lack of infectious disease expertise and previous anti-vaccine rhetoric. Currently, the CDC is monitoring over 40 individuals linked to cases on a Dutch cruise ship, though no domestic transmission has been confirmed. Critics argue this reflects a broader pattern of placing unqualified loyalists in critical health roles within the Trump administration.
A hantavirus outbreak aboard the MV Hondius cruise ship resulted in three deaths and multiple confirmed cases among passengers from 23 countries. Originating likely in Argentina, the rare Andes virus strain facilitated limited human-to-human transmission. The World Health Organization coordinated a complex international evacuation in Tenerife, Spain, repatriating over 120 individuals for mandatory quarantine. While the WHO assessed the global public health risk as low, the incident highlighted challenges in managing infectious diseases in maritime settings, leading to varied national containment protocols and secondary exposure incidents in healthcare facilities.
101 reports · 55 sources · Updated
Periodic recap
What changed for this subject in each tracking window — generated from matched events, delta-first.
→· 1 event in window
The Ebola outbreak in the Democratic Republic of Congo reached a critical turning point in this period, with the country launching a vaccination campaign targeting front-line healthcare workers. The outbreak continues to worsen, spreading to 60 health zones with over 6,000 confirmed cases and a death toll nearing 3,000. The World Health Organization's Emergency Committee held a second meeting on the epidemic and issued temporary recommendations.
The DRC launched an Ebola vaccination campaign for front-line healthcare workers as the outbreak spread to 60 health zones.
Confirmed cases surpassed 6,000 with deaths nearing 3,000, worsening from the nearly 5,000 cases and 2,300 deaths reported in the previous period.
The WHO Emergency Committee held a second meeting on the epidemic and issued temporary recommendations.
Earlier recaps
→· 1 event in window
This period tracked a sharp escalation of the Ebola outbreak in the Democratic Republic of Congo, marking a shift from the previous period's focus on U.S. vaccine policy to a public health crisis in Africa. Caused by the rare Bundibugyo virus, the outbreak has claimed over 2,300 lives with nearly 5,000 cases, and continues to spread at a rate of one death every 30 minutes. The World Health Organization warns it could become the worst Ebola outbreak in history, with response efforts severely hampered by the absence of approved vaccines, health worker strikes, and community mistrust.
→· 1 event in window
This period tracked a development in U.S. vaccine policy that intersects with the World Health Organization's long-standing public health positions. President Trump signed an executive order significantly reducing the number of recommended childhood vaccines and calling for the splitting of the MMR vaccine, based on debunked claims linking it to autism. The move drew strong opposition from health experts and lawmakers, who warned it heightens infection risks amid a major measles outbreak. This marks a shift from the previous period's focus on the Ebola outbreak in DRC to a U.S. domestic policy challenge to global vaccination consensus.
→· 1 event in window
A major event directly involving the WHO was tracked in this period: an Ebola outbreak caused by the Bundibugyo virus in eastern DRC has killed over 1,700 people. The WHO and Africa CDC are investigating a possible virus mutation, while the response is severely hampered by community mistrust, armed conflict, and a health worker strike. This marks a shift from the previous period, which lacked any directly linked organizational activity.
→· 1 event in window
Only one event related to the WHO was tracked in this period, concerning the ongoing severe wildfires across Southern and Western Europe. The event reports still do not directly mention specific WHO actions or statements, though the public health implications of large-scale disasters typically fall under the organization's purview. Given the lack of direct linkage, there is no substantive update on the organization's activities.
→· 1 event in window
Only one event related to the WHO was tracked in this period, concerning severe wildfires across Southern and Western Europe. The event itself does not directly mention WHO actions or statements, though large-scale disasters typically involve public health responses that may fall under the organization's purview. Given the lack of direct linkage, there is no substantive update on the organization's activities.
Tracked events
Events matched to this subject by the tracking pipeline, with signal scores.
· Signal 79.7
Congo begins vaccinations as fastest-growing Ebola outbreak spreads to 60 health zones
The Democratic Republic of the Congo has launched a vaccination campaign targeting front-line healthcare workers to combat its fastest-growing Ebola outbreak, which has spread to two new health zones, bringing the total affected areas to 60. Over 6,000 cases have been confirmed, with the death toll nearing 3,000. The World Health Organization’s Emergency Committee has held a second meeting on the epidemic, issuing temporary recommendations.